14 24 31 62 Pathway for patients with suspected Skin Cancer NB. Basal Cell Carcinoma is excluded from the 2 week cancer pathway Maximum wait in days 2ww referral received in secondary care Provide information and psychological support 14 First Specialist Assessment Clinical History Physical Examination Holistic assessment and rehabilitation consideration Yes Is SCC or MM Suspected? No Patient discharged with information on self assessment and prevention First treatment? Initial biopsy of lesion 10 Is SCC or MM confirmed? No Pathology results discussed with patient Patient discharged with information on self assessment and prevention Yes 16-18 years old – refer to Paediatric Oncology (GNCC) for treatment and TYA MDT for discussion 19-24 years old – continue on tumour site specific pathway & refer to TYA MDT for discussion. Is further treatment required? No Patient discharged with information on self assessment/prevention and follow up arranged See TYA pathway Inform patient’s GP Yes Allocate Skin CNS/ Key Worker Yes Local MDT discussion Inter provider transfer point 24 Refer for discussion at Specialist MDT as required Liaise & involve healthcare professionals as required 7 Specialist MDT to discuss investigation, treatment & Rehabilitation plan plus consideration for clinical trials Decision to treat date Treatment plan agreed with patient 31 FNA Imaging Sentinel Node Biopsy Further staging investigations as required 31 First treatment 62 Dermatology Plastic Surgery OMF Surgery Radiotherapy Chemotherapy Specialist MDT discussion Is further treatment required? Yes Earliest Clinically Appropriate Date for commencement of subsequent treatment ECAD Date No Appropriate after care Skin Cancer Pathway [Final]